CIPLA's weekly performance was disappointing, with a return of -4.49% and a max drawdown of the same magnitude, indicating a significant decline in value. The stock's volatility was relatively moderate at 9.46%, but its Sharpe Ratio of -2.55 suggests that the return was not justified by the level of risk taken. Compared to its peers, CIPLA underperformed, with SUNPHARMA and GRASIM experiencing smaller losses, and DIVISLAB posting a relatively smaller decline. Overall, the stock was relatively risky this week.

[Volatility: 9.46%]